Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C2orf44 |
| Upstream (Parents) |
|---|
| (<<) HHLA3 → C2orf44 |
| (<<) KIAA0319L → C2orf44 |
| (<<) FRS2 → C2orf44 |
| (<<) KIAA0090 → C2orf44 |
| (<<) NRIP1 → C2orf44 |
| (<<) PTPRB → C2orf44 |
| Downstream (Children) |
|---|
| C2orf44 → RAP2B (>>) |
| C2orf44 → ERAP1 (>>) |
| C2orf44 → CLUL1 (>>) |
| C2orf44 → GRAP (>>) |
| C2orf44 → ATRIP///TREX1 (>>) |
| C2orf44 → ING2 (>>) |
| C2orf44 → KLK3 (>>) |
| C2orf44 → FOXH1 (>>) |
| C2orf44 → ADAM19 (>>) |
| C2orf44 → HSPA6 (>>) |
| C2orf44 → FAM153C///FAM153A///FAM153B (>>) |
| C2orf44 → SCARA3 (>>) |
| C2orf44 → UBOX5 (>>) |
| C2orf44 → KIAA0319L (>>) |
| C2orf44 → FRS2 (>>) |
| C2orf44 → ARID1A (>>) |
| C2orf44 → WDTC1 (>>) |
| C2orf44 → RAB40B (>>) |
| C2orf44 → MECP2 (>>) |
